Emergent Biosolutions
EBS
EBS
203 hedge funds and large institutions have $1.15B invested in Emergent Biosolutions in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 93 increasing their positions, 64 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
-21
Holders Change %
-9.38%
% of All Funds
5.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
93
Reduced
64
Closed
42
Calls
$4.18M
Puts
$1.17M
Net Calls
+$3.01M
Net Calls Change
+$11.9M
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$958K |
| 2 |
2
D.E. Shaw & Co
New York
|
$16.8M |
| 3 |
AL
3
AJO LP
Philadelphia,
Pennsylvania
|
$4.52M |
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
|
$6.51M |
| 5 |
NI
5
Numeric Investors
Boston,
Massachusetts
|
$3.27M |
